| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC0173 |
| Trial ID | NCT01864889 |
| Disease | Mantle Cell Lymphoma | Follicular Lymphoma | Diffuse Large B-Cell Lymphoma | Prolymphocytic Leukemia | Acute Lymphoblastic Leukemia |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD19 CAR-T cells |
| Generation | 2nd |
| Recruitment status | Unknown |
| Title | Treatment of Relapsed and/or Chemotherapy Refractory B-cell Malignancy by CART19 |
| Year | 2013 |
| Country | China |
| Company sponsor | Chinese PLA General Hospital |
| Other ID(s) | CHN-PLAGH-BT-005 |
| Vector information | |||||
|
|||||
| Cohort 1 | |||||||||||||||||||
|
|||||||||||||||||||